Clinical Trial

Evaluation of the Effect of Para-sternal Block on Postoperative Respiratory Function After Cardiac Sternotomy Surgery

Study acronym: PARACARD
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated May 28, 2025 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
Summary
Postoperative pain after cardiac surgery is associated with reduced postoperative respiratory function. There is an association between greater pain and more pronounced decreases in lung volumes postoperatively. With an incidence of 10% to 25% of cases, pulmonary complications are the second source of postoperative morbidity after cardiac complications; in 2-5% of cases, the dysfunction is severe and leads to significant consequences that can lead to death. It has been shown that postoperative pain after cardiac surgery is associated with a reduction in functional respiratory capacity. There is an association between greater pain and more pronounced decreases in lung volumes postoperatively. The main objective of this study will be to evaluate the impact of locoregional anesthesia by parasternal block analgesic on postoperative respiratory function at D1 postoperatively
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-08-23; most recent amendment 2025-05-22.
Status change: Recruiting → Active, Not Recruiting 2025-05-22
Trial Details
NCT Number NCT05515809
Lead Sponsor Centre Hospitalier Universitaire, Amiens
Conditions Cardiac Surgery, Ultrasound-guided Parasternal Block, Postoperative Pulmonary Complications, Pulmonary Function Testing
Enrollment 84 participants
Start Date 2022-07-19
Primary Completion 2025-06 (estimated)
Study Completion 2025-06 (estimated)
Updated on ClinicalTrials.gov 2025-05-28